At the time of writing, Windtree Therapeutics Inc [WINT] stock is trading at $0.70, down -12.51%. An important factor to consider is whether the stock is rising or falling in short-term value. The WINT shares have gain 5.20% over the last week, with a monthly amount drifted -23.05%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Windtree Therapeutics Inc [NASDAQ: WINT] stock has seen the most recent analyst activity on June 26, 2020, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $12.25.
For the past year, the stock price of Windtree Therapeutics Inc fluctuated between $0.52 and $737.43. Windtree Therapeutics Inc [NASDAQ: WINT] shares were valued at $0.70 at the most recent close of the market.
Analyzing the WINT fundamentals
Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -482.98%, Pretax Profit Margin comes in at -359.36%, and Net Profit Margin reading is -461.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.78, Equity is -3.21 and Total Capital is -1.07. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.36.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6468 points at the first support level, and at 0.5938 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7689, and for the 2nd resistance point, it is at 0.8380.
Ratios To Look Out For
It is important to note that Windtree Therapeutics Inc [NASDAQ:WINT] has a current ratio of 0.25. On the other hand, the Quick Ratio is 0.25, and the Cash Ratio is 0.18.
Transactions by insiders
Recent insider trading involved Fraser Craig, President and CEO, that happened on Oct 08 ’24 when 5431.0 shares were purchased.
